Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T J Maling

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
The New Zealand Medical Journal|February 8, 1984
Beta blocker withdrawal: the role of the beta adrenoceptorT J Maling
Pharmacoeconomics|June 7, 1994
The New Zealand preferred medicines concept: a national scheme for audit and quality assurance of prescribingT J Maling
The New Zealand Medical Journal|September 24, 1999
Third generation oral contraceptives and the risk of venous thromboembolism: management of the uncertaintyT J Maling
The New Zealand Medical Journal|March 28, 1984
Debendox: a statement from the New Zealand Adverse Drug Reactions CommitteeT J Maling
The New Zealand Medical Journal|February 8, 1989
The prescribing process and options for modificationT J Maling
The New Zealand Medical Journal|April 8, 1987
Compensation for medicine-induced injury in clinical trialsT J Maling
The New Zealand Medical Journal|January 27, 1982
Potassium supplements--a practical viewT J Maling
The New Zealand Medical Journal|May 23, 1990
Minimum effective dosage in the drug treatment of hypertension: a cost effective strategy for prescribersT J Maling, I Kawachi
The New Zealand Medical Journal|August 22, 1990
Beta blocker dose titration in the drug treatment of hypertensionT J Maling, I Kawachi
Journal of Cardiovascular Pharmacology|January 1, 1990
Sodium-lithium countertransport is not a marker of proximal tubular sodium clearanceT J Maling, R W Siebers
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
The New Zealand Medical Journal|February 8, 1984
Beta blocker withdrawal: the role of the beta adrenoceptorT J Maling
Pharmacoeconomics|June 7, 1994
The New Zealand preferred medicines concept: a national scheme for audit and quality assurance of prescribingT J Maling
The New Zealand Medical Journal|September 24, 1999
Third generation oral contraceptives and the risk of venous thromboembolism: management of the uncertaintyT J Maling
The New Zealand Medical Journal|March 28, 1984
Debendox: a statement from the New Zealand Adverse Drug Reactions CommitteeT J Maling
The New Zealand Medical Journal|February 8, 1989
The prescribing process and options for modificationT J Maling
The New Zealand Medical Journal|April 8, 1987
Compensation for medicine-induced injury in clinical trialsT J Maling
The New Zealand Medical Journal|January 27, 1982
Potassium supplements--a practical viewT J Maling
The New Zealand Medical Journal|May 23, 1990
Minimum effective dosage in the drug treatment of hypertension: a cost effective strategy for prescribersT J Maling, I Kawachi
The New Zealand Medical Journal|August 22, 1990
Beta blocker dose titration in the drug treatment of hypertensionT J Maling, I Kawachi
Journal of Cardiovascular Pharmacology|January 1, 1990
Sodium-lithium countertransport is not a marker of proximal tubular sodium clearanceT J Maling, R W Siebers
Pageof 6